• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

戊糖部分修饰和构象变化对核苷配体与刚地弓形虫尿苷磷酸化酶结合的影响。

Effects of modifications in the pentose moiety and conformational changes on the binding of nucleoside ligands to uridine phosphorylase from Toxoplasma gondii.

作者信息

el Kouni M H, Naguib F N, Panzica R P, Otter B A, Chu S H, Gosselin G, Chu C K, Schinazi R F, Shealy Y F, Goudgaon N, Ozerov A A, Ueda T, Iltzsch M H

机构信息

Department of Pharmacology and Toxicology, University of Alabama at Birmingham 35294, USA.

出版信息

Biochem Pharmacol. 1996 Jun 28;51(12):1687-700. doi: 10.1016/0006-2952(96)00213-4.

DOI:10.1016/0006-2952(96)00213-4
PMID:8687484
Abstract

One hundred and fifty analogues of uridine, with various modifications to the uracil and pentose moieties, have been tested and compared with uridine with respect to their potency to bind to uridine phosphorylase (UrdPase, EC 2.4.2.3) from Toxoplasma gondii. The effects of the alpha- and beta-anomers, the L- and D-enantiomers, as well as restricted syn and anti rotamers, on binding were examined. Pseudo-, lyxo-, 2,3'-anhydro-2'-deoxy-, 6,5'-cyclo-, 6,3'-methano-, O5',6-methano- and carbocyclic uridines did not bind to the enzyme. Ribosides bound better than the corresponding xylosides, which were better than the deoxyribosides. The binding of deoxyribosides was in the following manner: 2',3'-dideoxynucleosides > 2',5'-dideoxynucleosides > 2'-deoxyribosides > 3'- and 5'-deoxyribosides. alpha-2'-Deoxyribosides bound to the enzyme, albeit less tightly than the corresponding beta-anomers. The acyclo- and 2,2'-anhydrouridines bound strongly, with the 2,2'-anhydro-derivatives being the better ligands. 2,5'-Anhydrouridine bound to UrdPase less effectively than 2,2'-anhydrouridine and acyclouridine. Arabinosyluracil was at best a very poor ligand, but bound better if a benzyl group was present at the 5-position of the pyrimidine ring. This binding was enhanced further by adding a 5-benzyloxybenzyl group. A similar enhancement of the binding by increased hydrophobicity at the 5-position of the pyrimidine ring was observed with ribosides, alpha- and beta-anomers of the 2'-deoxyribosides, acyclonucleosides, and 2,2'-anhydronucleosides. Among all the compounds tested, 5-(benzyloxybenzyl)-2,2'-anhydrouridine was identified as the best ligand of T. gondii UrdPase with an apparent Ki value of 60 +/- 3 nM. It is concluded that the presence of an N-glycosyl bond is a prerequisite for a nucleoside ligand to bind to T. gondii UrdPase. On the other hand, the presence of a 2'-, 3'-, or 5'-hydroxyl group, or an N-glycosyl bond in the beta-configuration, enhanced but was not essential for binding. Furthermore, the potency of the binding of 2,2'-anhydrouridines (fixed high syn isomers) in contrast to the weaker binding of the 6,1'-anhydro- or 2,5'-anhydrouridines (fixed syn isomers), and the complete lack of binding of the 6,5'-cyclo, O5',6-methano- and 6,3'-methanouridines (fixed anti isomers) to T. gondii UrdPase indicate that the binding of ligands to this enzyme is in the syn/high syn conformation around the N-glycosyl bond. The results also indicate that the parasite but not the mammalian host UrdPase can participate in hydrogen bonding with N3 of the pyrimidine ring of nucleoside ligands. T. gondii UrdPase also has a larger hydrophobic pocket adjacent to the C5 of the pyrimidine moiety than the host enzyme, and can accommodate modifications in the pentose moiety which cannot be tolerated by the host enzyme. Most prominent among these modifications is the absence and/or lack of the ribo orientation of the 3'-hydroxyl group, which is a requirement for a ligand to bind to mammalian UrdPase. These differences between the parasite and host, enzymes can be useful in designing specific inhibitors or "subversive" substrates for T. gondii UrdPase.

摘要

已对150种尿苷类似物进行了测试,这些类似物在尿嘧啶和戊糖部分有各种修饰,并就它们与来自刚地弓形虫的尿苷磷酸化酶(UrdPase,EC 2.4.2.3)的结合能力与尿苷进行了比较。研究了α-和β-端基异构体、L-和D-对映体以及受限的顺式和反式旋转异构体对结合的影响。假尿苷、来苏糖型尿苷、2,3'-脱水-2'-脱氧尿苷、6,5'-环尿苷、6,3'-亚甲基尿苷、O5',6-亚甲基尿苷和碳环尿苷不与该酶结合。核糖核苷的结合优于相应的木糖核苷,而木糖核苷又优于脱氧核糖核苷。脱氧核糖核苷的结合情况如下:2',3'-二脱氧核苷>2',5'-二脱氧核苷>2'-脱氧核糖核苷>3'-和5'-脱氧核糖核苷。α-2'-脱氧核糖核苷能与该酶结合,尽管结合力比相应的β-端基异构体弱。无环尿苷和2,2'-脱水尿苷结合力强,其中2,2'-脱水衍生物是更好的配体。2,5'-脱水尿苷与UrdPase的结合效果不如2,2'-脱水尿苷和无环尿苷。阿拉伯糖基尿嘧啶充其量是一种非常差的配体,但如果嘧啶环的5位存在苄基,则结合更好。通过添加5-苄氧基苄基,这种结合进一步增强。在核糖核苷、2'-脱氧核糖核苷的α-和β-端基异构体、无环核苷和2,2'-脱水核苷中,也观察到嘧啶环5位疏水性增加导致结合增强。在所有测试的化合物中,5-(苄氧基苄基)-2,2'-脱水尿苷被确定为刚地弓形虫UrdPase的最佳配体,其表观Ki值为60±3 nM。得出的结论是,N-糖苷键的存在是核苷配体与刚地弓形虫UrdPase结合的先决条件。另一方面,2'-、3'-或5'-羟基的存在,或β-构型的N-糖苷键的存在,增强了结合,但不是结合所必需的。此外,2,2'-脱水尿苷(固定的高顺式异构体)的结合能力较强,而6,1'-脱水-或2,5'-脱水尿苷(固定的顺式异构体)的结合能力较弱,以及6,5'-环尿苷、O5',6-亚甲基尿苷和6,3'-亚甲基尿苷(固定的反式异构体)完全不与刚地弓形虫UrdPase结合,这表明配体与该酶的结合是围绕N-糖苷键以顺式/高顺式构象进行的。结果还表明,寄生虫而非哺乳动物宿主的UrdPase可以与核苷配体嘧啶环的N3形成氢键。刚地弓形虫UrdPase在嘧啶部分的C5附近也有一个比宿主酶更大的疏水口袋,并且可以容纳宿主酶无法耐受的戊糖部分的修饰。这些修饰中最突出的是3'-羟基核糖取向的缺失和/或缺乏,而这是配体与哺乳动物UrdPase结合的一个要求。寄生虫和宿主酶之间的这些差异可用于设计针对刚地弓形虫UrdPase的特异性抑制剂或“颠覆性”底物。

相似文献

1
Effects of modifications in the pentose moiety and conformational changes on the binding of nucleoside ligands to uridine phosphorylase from Toxoplasma gondii.戊糖部分修饰和构象变化对核苷配体与刚地弓形虫尿苷磷酸化酶结合的影响。
Biochem Pharmacol. 1996 Jun 28;51(12):1687-700. doi: 10.1016/0006-2952(96)00213-4.
2
Effect of the N-glycosidic bond conformation and modifications in the pentose moiety on the binding of nucleoside ligands to uridine phosphorylase.戊糖部分中N-糖苷键构象和修饰对核苷配体与尿苷磷酸化酶结合的影响。
Mol Pharmacol. 1988 Aug;34(2):104-10.
3
New analogues of benzylacyclouridines, specific and potent inhibitors of uridine phosphorylase from human and mouse livers.
Biochem Pharmacol. 1987 Jul 1;36(13):2195-201. doi: 10.1016/0006-2952(87)90150-x.
4
Differences in activities and substrate specificity of human and murine pyrimidine nucleoside phosphorylases: implications for chemotherapy with 5-fluoropyrimidines.人和小鼠嘧啶核苷磷酸化酶的活性及底物特异性差异:对5-氟嘧啶化疗的影响。
Cancer Res. 1993 Aug 15;53(16):3687-93.
5
Structure-activity relationship of nucleobase ligands of uridine phosphorylase from Toxoplasma gondii.
Biochem Pharmacol. 1993 Nov 17;46(10):1849-58. doi: 10.1016/0006-2952(93)90592-k.
6
The effect of the 3'-OH group on the conformation and binding ability of anhydropyrimidine nucleosides to uridine phosphorylase.3'-羟基对无环嘧啶核苷的构象及与尿苷磷酸化酶结合能力的影响。
Arch Biochem Biophys. 1991 Apr;286(1):1-5. doi: 10.1016/0003-9861(91)90001-y.
7
5-phenylthioacyclouridine: a potent and specific inhibitor of uridine phosphorylase.
Biochem Pharmacol. 2000 Sep 15;60(6):851-6. doi: 10.1016/s0006-2952(00)00410-x.
8
Structure-activity relationship for the binding of nucleoside ligands to adenosine kinase from Toxoplasma gondii.核苷配体与刚地弓形虫腺苷激酶结合的构效关系
Biochem Pharmacol. 1995 May 17;49(10):1501-12. doi: 10.1016/0006-2952(95)00029-y.
9
Effect of administration of 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase, on the anti-tumor efficacy of 5-fluoro-2'-deoxyuridine against murine colon tumor C26-10.尿苷磷酸化酶抑制剂5-(苯硒基)无环尿苷的给药对5-氟-2'-脱氧尿苷抗小鼠结肠肿瘤C26-10疗效的影响。
Biochem Pharmacol. 2000 Sep 1;60(5):687-92. doi: 10.1016/s0006-2952(00)00375-0.
10
Substrate specificity of E. coli uridine phosphorylase. Further evidences of high-syn conformation of the substrate in uridine phosphorolysis.大肠杆菌尿苷磷酸化酶的底物特异性。尿苷磷酸解中底物高顺式构象的进一步证据。
Nucleosides Nucleotides Nucleic Acids. 2017 Feb;36(2):107-121. doi: 10.1080/15257770.2016.1223306. Epub 2016 Nov 15.

引用本文的文献

1
Pyrimidine metabolism in schistosomes: A comparison with other parasites and the search for potential chemotherapeutic targets.血吸虫嘧啶代谢:与其他寄生虫的比较及潜在化疗靶点的探索
Comp Biochem Physiol B Biochem Mol Biol. 2017 Nov;213:55-80. doi: 10.1016/j.cbpb.2017.07.001. Epub 2017 Jul 21.
2
Avirulent uracil auxotrophs based on disruption of orotidine-5'-monophosphate decarboxylase elicit protective immunity to Toxoplasma gondii.基于乳清酸-5'-单磷酸脱羧酶的缺陷型无毒尿嘧啶营养缺陷型能够引发对刚地弓形虫的保护性免疫。
Infect Immun. 2010 Sep;78(9):3744-52. doi: 10.1128/IAI.00287-10. Epub 2010 Jul 6.